Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou cannot safely take half an injection of Wegovy. Each Wegovy pen is factory-set to deliver one complete, pre-measured dose; there is no mechanism to stop it mid-injection or split the volume. Dose adjustments are made by prescribers through the licensed titration schedule, not by dividing individual pens. These are prescription-only medicines, and any change to how they are taken requires clinical guidance rather than a workaround at home.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A Wegovy pen is not a syringe you fill yourself. It comes pre-loaded with one week's dose, and the injection mechanism releases the full volume in a single press. Once you activate it, the device is designed to complete the injection, stopping partway delivers an uncertain amount of medicine, not a clean half-dose. The pen then locks, so you cannot use the remainder. You'd be discarding medicine, getting an unmeasured quantity, and none of it is accounted for in the prescriber's plan for you.
There is also a pharmacology point worth understanding. Semaglutide has a long biological half-life of roughly seven days, which you can read about in more detail on our semaglutide half-life guide. It builds in the body across weekly injections, reaching a steady therapeutic level over several weeks. If you are specifically starting on the introductory strength, our page on the half-life of the 0.25 mg Wegovy dose explains how that earliest stage behaves in the body. A partial dose on one occasion does not map neatly onto the idea of a lower dose for that week, the residual level from previous injections is still circulating, and our guide to Wegovy's peak concentration and half-life covers exactly why that matters across the weekly cycle. The NHS medicines page for semaglutide explains the pharmacokinetic profile clearly if you want the official patient-level description.
The misconception that you can fine-tune your dose at home by stopping the pen early is understandable, people are used to tablets that can be halved. Injections simply do not work that way, and acting on that assumption could mean you are taking an unknown amount of an active prescription medicine each week.
Wegovy's licensed schedule starts at 0.25 mg and steps upward through 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg, with at least four weeks at each level. That structure is not arbitrary. The lower starting doses are specifically designed to let your body adjust and to reduce the likelihood of gastrointestinal side effects (nausea, stomach discomfort, loose stools) that many people notice at the beginning of treatment or after a dose increase. This is the mechanism by which a prescriber achieves a lower effective dose: not by splitting a pen, but by using the appropriate pen for that stage of the schedule.
If side effects are the reason you are wondering about halving a dose, that is important information for your prescribing team. Staying longer at a lower dose, pausing a planned increase, or revisiting the titration timeline are all legitimate clinical decisions. They are just ones that belong in a consultation, not a kitchen drawer. For more context on how the medicine's activity fits the weekly cycle, the Wegovy mechanism and action page goes into further detail.
Prescribers at services like ours review these decisions before every repeat, that review exists precisely so that the right dose for your situation is the one you actually receive.
Two practical situations drive most questions about halving a Wegovy injection. The first is side effects: a dose that feels too strong is a real and legitimate concern. The correct path is to contact your prescribing service and have that conversation. A prescriber can formally hold you at a lower dose, which means you receive the right pre-set pen for that dose rather than trying to improvise with a higher one. Our support team is available seven days a week if you are a nume patient and need to raise this.
The second situation is cost. Wegovy is a private prescription, and the expense of running multiple pens per month is real. Our Wegovy pricing page covers what honest private treatment costs and what that price includes. If a lower maintenance dose is clinically appropriate, it may reduce cost naturally, but that is a clinical judgement, not a DIY solution. Splitting a pen to stretch supply is not a safe workaround, and it is worth being honest with your prescriber about financial pressures, because they can sometimes adjust the plan in ways that are both clinically sound and practically sustainable.
You can explore the full context of treatment options, including how to access a review with one of our prescribers, on the weight-loss treatments overview page. The Wegovy information page also covers the licence, eligibility, and what to expect across the titration schedule.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.